Your source for the latest medtech news from AdvaMed and our members.
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on the Trump Administration’s budget proposal to improve Medicare beneficiary access…
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation (S. 692) – the Protect Medical Innovation…
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on the resignation of FDA Commissioner Scott Gottlieb: “We want to thank Dr.…
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of legislation in the U.S. House of Representatives to…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
Leading Health Groups Challenge GAO’s Flawed Report on Medicare Lab Billing February 25, 2019 Washington, D.C. – In response to broad and misleading claims in a recent Government Accountability…
Washington, D.C.— AdvaMedDx has submitted comments on draft legislation, the Verifying Accurate Leading-Edge IVCT Development (VALID) Act, commending Congress for their support of comprehensive, risk-based diagnostics regulatory reform. “An overarching,…
The Advanced Medical Technology Association (AdvaMed) today announced that Amanda Walsh has joined the association as its associate vice president for government affairs.
WASHINGTON, D.C. – A medical technology and health IT task force of medical device manufacturers, trade associations, FDA representatives and other health industry stakeholders – operating as part of the…
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Washington, D.C. – The medical technology community is already feeling the effects of the partial government shutdown. Under current law, FDA cannot review new fee-paying medical device applications for market…